Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 3Pancreatic Neoplasms 3Urinary Bladder Neoplasms 2Postoperative Complications 2Malnutrition 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Urinary Bladder, Neurogenic 1Urinary Bladder Diseases 1Small Cell Lung Carcinoma 1Neoplasms 1Gastrointestinal Neoplasms 1Frailty 1Esophagitis 1Endometriosis 1Cystitis, Interstitial 1Cystitis, Hemorrhagic 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Sorafenib 131lenvatinib 115Bevacizumab 88Radiosurgery 69atezolizumab 55sintilimab 54Nivolumab 51durvalumab 43Hepatectomy 43Fluorouracil 42apatinib 41Oxaliplatin 41camrelizumab 38Radiofrequency Ablation 38pembrolizumab 36Radiotherapy 36tislelizumab 35Leucovorin 31Magnetic Resonance Spectroscopy 30Immune Checkpoint Inhibitors 28Doxorubicin 28Folfox protocol 26tremelimumab 25regorafenib 25Cisplatin 20spartalizumab 19donafenib 19Gemcitabine 19Cyclophosphamide 19toripalimab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Hepatocellular × Immunonutrition Diet × Clear all
NCT07395635 2026-02-09

Phase II Trial of Immunonutrition in Hepatectomy

Tata Memorial Centre

Phase NA Recruiting
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡